[1] |
XU Yiqi, WU Qian, LIU Shu, LIU Fan, XING Chunyan, LI Qin, HE Junjun, HE Chunling, ZHAO Yongli, GAO Jialin.
Clinical efficacy and anti-inflammation/anti-fibrosis effect of tripterygium glycosides in the treatment of diabetic nephropathy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1034-1042.
|
[2] |
XIAO Yue, LI Tangfei, XUE Qianfu.
Analysis of the efficacy and safety of Peg-IFN-α in the treatment of essential thrombocythemia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1049-1055.
|
[3] |
ZHANG Wei, LIU Lei, GUAN Shaoyang, SHENG Zhao, SUN Wenwen.
Analysis of the diagnostic value of fine-needle aspiration cytology and BRAF and RAS gene mutation screening for thyroid cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 653-657.
|
[4] |
PENG Yong, FAN Jianfeng, XIONG Xuhua, XIAO Dongping, GAO Zhaobo, ZHENG Chunhua.
Effect of iron dextran dispersible tablets on heart failure patients with iron deficiency
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 178-183.
|
[5] |
HUANG Yurong, ZHANG Hongqiang, YOU Rongli, JIA Ying, WANG Yan, FAN Jie, WANG Yingli.
Study on the improvement of Qingdaipowder Gel for external use on mice with specific dermatitis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 19-28.
|
[6] |
HUANG Xiaoming, DU Ye, LIN Shaoming, SHEN Guanle.
Exploratory study of the influence of respiratory microbiology on the efficacy of PD-1 inhibitors monotherapy for patients with advanced non-small cell lung cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 66-74.
|
[7] |
HONG Ziqiang, GOU Wenxi, CUI Baiqiang, BAI Xiangdou, JIN Dacheng, GOU Yunjiu.
Role of the m7G methyltransferase METTL1 in tumours
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 93-100.
|
[8] |
XU Tao, ZHU Suyan, QIU Xiangjun, XU Ping.
Population pharmacokinetics of teicoplanin in patients with renal insufficiency
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 977-983.
|
[9] |
MA Shen, LIU Yushuo, TANG Hui, CHEN Wenbin, GAO Ling.
Pharmacokinetics and clinical significance of drugs for improving nonalcoholic fatty liver disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 908-918.
|
[10] |
LIANG Meifang, CHEN Qingzhuang, YANG Peiqun, WANG Yong.
Efficacy and safety of generic and branded atorvastatin in patients with ischemic stroke/transient ischemic attack: A real-world study
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 785-792.
|
[11] |
LIU Xing, LU Xiaoran, WU Ying, YU Haitao, WANG Xiaomin.
Ethical analysis and countermeasures of artificial intelligence application in clinical trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 322-327.
|
[12] |
MENG Shi, WANG Zhongqun.
Research progress on human immunodeficiency virus-associated pulmonary arterial hypertension
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(12): 1431-1440.
|
[13] |
YANG Mengjiao, YUAN Hao, ZHENG Ya, WANG Yuping, GUO Qinghong.
Advances in the treatment of potassium-competitive acid blockers in reflux esophagitis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(10): 1190-1196.
|
[14] |
HU Yin, YANG Dandan, XU Yichao, SHAO Rong, RUAN Zourong, JIANG Bo, CHEN Jinliang, LOU Honggang.
Application of artificial neural network model in bioequivalence study of candesartan cilexetil tablets
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(1): 63-69.
|
[15] |
GAO Lili, CHEN Rui, LI Lujin, ZHENG Qingshan .
Dose selection of obeticholic acid in hepatic impairment patients and the review consideration of FDA
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(7): 760-767.
|